AI-mediated ultrasound radiomics in the diagnosis and treatment of triple-negative breast cancer: research progress and future challenges - Report - MDSpire
Advertisement
AI-mediated ultrasound radiomics in the diagnosis and treatment of triple-negative breast cancer: research progress and future challenges
Clinical Report: Advancements and Challenges in AI-Enhanced Ultrasound Radiomics
Overview
AI-mediated ultrasonic radiomics offers promising advancements in the diagnosis and treatment of triple-negative breast cancer (TNBC) by enhancing the accuracy of tumor characterization and prognostic assessments. However, challenges such as data standardization and model interpretability hinder its routine clinical application.
Background
Triple-negative breast cancer (TNBC) represents a significant clinical challenge due to its aggressive nature, limited treatment options, and poor prognosis. Accurate early diagnosis and individualized treatment strategies are crucial for improving patient outcomes. The integration of artificial intelligence (AI) in ultrasound radiomics presents a novel approach to address these challenges by enabling non-invasive tumor characterization.
Data Highlights
No specific numerical data provided in the article.
Key Findings
AI-driven ultrasonic radiomics has evolved from basic differential diagnosis to multi-subtype classification for TNBC.
Models can effectively predict disease-free survival (DFS) and overall survival (OS) by integrating various tumor features.
Challenges include insufficient standardized data protocols and limited model interpretability.
Multimodal image fusion enhances diagnostic performance in TNBC.
Future research should focus on establishing standardized workflows and conducting multicenter validation studies.
Clinical Implications
Healthcare professionals should consider the potential of AI-enhanced ultrasound radiomics in improving diagnostic accuracy and treatment planning for TNBC. However, they must remain aware of the current limitations and the need for further validation before widespread clinical implementation.
Conclusion
AI-enhanced ultrasound radiomics holds promise for transforming the diagnosis and treatment of TNBC, but addressing existing challenges is essential for its successful integration into clinical practice.
